The Marked Chart Wire · Business
Daybue
Kyorin signs Japan deal for Acadia's Rett syndrome drug
Kyorin Pharmaceutical has entered an exclusive distribution agreement with Acadia Pharmaceuticals for Daybue Stix in Japan. The deal includes a $30 million upfront payment and up to $45 million in milestone payments.
